Is a complete BUL/038 research report available?

No complete published report is available for bul/038 (BUL/038) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bul/038 stock profile | StockMarketAgent.AI

Zaloguj się Start free

BUL/038 (BUL/038)

Bulgarian Stock Exchange: BUL/038 · EUR

€12.1

+0.00 (0.0%)· Recorded snapshot

Market cap	1.4B
Revenue (ttm)	638.8M
Net income (ttm)	-107.2M
EPS (ttm)	-€0.95

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 638.8M
Net income (ttm): -107.2M
EPS (ttm): -€0.95
Market cap: 1.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All BUL/038 indicators

Market & fundamental data

Available fields

125

Groups with data

Currency

USD

Showing 125 of 125 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Jersey
Country code	BG
Earnings date	2027-02-25
Employees	1,605
Employees change	117
Employees growth	7.86%
Enterprise value	EUR 1.2B
Exchange	Bulgarian Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-11-03
Fiscal year end	December
Founded	2000
Industry	Medical Devices
Is primary listing	No
ISIN number	JE00BYSS4X48
Last refreshed	2026-11-03
Market cap	EUR 1.4B
Next earnings date	2027-02-25
Price	EUR 12.09
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-11-02
Symbol	bul/038
Website	https://www.novocure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-7.84%
EV/Sales	1.81x
FCF / EV yield	-1.85%
FCF yield	-1.57%
P/B ratio	4.47x
P/S ratio	2.16x
Price / tangible book value	4.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-16.41%
EBITDA margin	-14.27%
Gross margin	77.25%
Operating margin	-16.41%
Pretax margin	-18%
Profit margin	-16.78%
Profit per employee	EUR -66,788
Revenue per employee	EUR 397,992
ROA	-6.79%
ROA (5Y)	-7.44%
ROCE	-21.33%
ROE	-35.18%
ROE (5Y)	-34.39%
ROIC	-95.37%
SBC / revenue	16.17%
Tax / revenue	-1.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	2
FCF growth (Q)	5.54%
FCF growth (QoQ)	1,194.9%
Gross profit growth	15.52%
Gross profit growth (Q)	21.55%
Gross profit growth 3Y	13.83%
Gross profit growth 5Y	5.3%
Net income growth quarters	2
Net income growth years	2
OCF growth (Q)	10.17%
OCF growth (QoQ)	178.74%
Revenue growth	12.94%
Revenue growth (Q)	15.67%
Revenue growth (QoQ)	5.35%
Revenue growth 10Y	27.28%
Revenue growth 3Y	12.91%
Revenue growth 5Y	5.86%
Revenue growth quarters	12
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -21M
Depreciation and amortization	EUR 13.9M
EBIT	EUR -104.8M
EBITDA	EUR -91.1M
EPS	EUR -0.95
Financing cash flow	EUR -485.6M
Free cash flow	EUR -21.7M
Free cash flow minus SBC	EUR -125M
Gross profit	EUR 493.5M
Income taxes	EUR -7.8M
Investing cash flow	EUR 276.9M
Net borrowing	EUR -501.2M
Net cash flow	EUR -209.4M
Net income	EUR -107.2M
Operating cash flow minus SBC	EUR -103.9M
Operating income	EUR -104.8M
Revenue	EUR 638.8M
Stock-based compensation	EUR 103.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.69
Book value per share	EUR 2.74
Debt / equity	0.66
Interest coverage	-4.3
Long-term assets	EUR 128M
Long-term liabilities	EUR 179.2M
Net cash (debt)	EUR 204.2M
Net cash / market cap	14.81%
Net cash growth	-1.54%
Net debt / equity	-0.66
Piotroski F-Score	5
Property, plant and equipment	EUR 128.7M
Shareholders' equity	EUR 308.7M
Tangible book value	EUR 308.7M
Tangible book value per share	EUR 2.74
Total assets	EUR 729.8M
Total cash	EUR 408.1M
Total debt	EUR 203.9M
Total liabilities	EUR 421M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	EUR 601.8M
Current liabilities	EUR 241.8M
Current ratio	2.49
Inventory turnover	4.14
Net working capital	EUR -31.4M
Quick ratio	2.3
Working capital	EUR 354.8M
Working capital turnover	1.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.87%
Shareholder yield	-3.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96.9M
Shares change (QoQ)	0.67%
Shares change (YoY)	3.87%
Shares held by insiders	8.65%
Shares held by institutions	82.34%
Short ratio	8.9 days

BUL/038 (BUL/038)

Price

Financial snapshot

Fair-value bridge

Latest news · BUL/038

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BUL/038 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BUL/038

Frequently asked questions